These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25243792)

  • 41. The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.
    Ngollo M; Lebert A; Dagdemir A; Judes G; Karsli-Ceppioglu S; Daures M; Kemeny JL; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
    BMC Cancer; 2014 Dec; 14():994. PubMed ID: 25535400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins.
    Gui T; Bai H; Zeng J; Zhong Z; Cao D; Cui Q; Chen J; Yang J; Shen K
    Onco Targets Ther; 2014; 7():1705-16. PubMed ID: 25285018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma.
    Wasenang W; Puapairoj A; Settasatian C; Proungvitaya S; Limpaiboon T
    Pathol Res Pract; 2019 Jul; 215(7):152451. PubMed ID: 31126817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells.
    Choudhury SR; Balasubramanian S; Chew YC; Han B; Marquez VE; Eckert RL
    Carcinogenesis; 2011 Oct; 32(10):1525-32. PubMed ID: 21798853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
    Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
    Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polycomb gene expression and histone H3 lysine 27 trimethylation changes during bovine preimplantation development.
    Ross PJ; Ragina NP; Rodriguez RM; Iager AE; Siripattarapravat K; Lopez-Corrales N; Cibelli JB
    Reproduction; 2008 Dec; 136(6):777-85. PubMed ID: 18784248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.
    Tamagawa H; Oshima T; Numata M; Yamamoto N; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Yukawa N; Rino Y; Masuda M; Miyagi Y
    Eur J Surg Oncol; 2013 Jun; 39(6):655-61. PubMed ID: 23523318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.
    Chinaranagari S; Sharma P; Chaudhary J
    Oncotarget; 2014 Aug; 5(16):7172-82. PubMed ID: 25115397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients.
    Cai MY; Hou JH; Rao HL; Luo RZ; Li M; Pei XQ; Lin MC; Guan XY; Kung HF; Zeng YX; Xie D
    Mol Med; 2011; 17(1-2):12-20. PubMed ID: 20844838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
    Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ
    Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma.
    He LR; Liu MZ; Li BK; Rao HL; Liao YJ; Guan XY; Zeng YX; Xie D
    BMC Cancer; 2009 Dec; 9():461. PubMed ID: 20028503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells.
    Mochizuki-Kashio M; Mishima Y; Miyagi S; Negishi M; Saraya A; Konuma T; Shinga J; Koseki H; Iwama A
    Blood; 2011 Dec; 118(25):6553-61. PubMed ID: 22042701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade.
    Hoffmann F; Niebel D; Aymans P; Ferring-Schmitt S; Dietrich D; Landsberg J
    Clin Epigenetics; 2020 Feb; 12(1):24. PubMed ID: 32041674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polycomb group protein-mediated histone modifications during cell differentiation.
    Khan AA; Lee AJ; Roh TY
    Epigenomics; 2015; 7(1):75-84. PubMed ID: 25687468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target.
    Agarwal P; Alzrigat M; Párraga AA; Enroth S; Singh U; Ungerstedt J; Österborg A; Brown PJ; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
    Oncotarget; 2016 Feb; 7(6):6809-23. PubMed ID: 26755663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma.
    Yonemitsu Y; Imazeki F; Chiba T; Fukai K; Nagai Y; Miyagi S; Arai M; Aoki R; Miyazaki M; Nakatani Y; Iwama A; Yokosuka O
    Hum Pathol; 2009 Sep; 40(9):1304-11. PubMed ID: 19386347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. H3K27me3 is an Epigenetic Mark of Relevance in Endometriosis.
    Colón-Caraballo M; Monteiro JB; Flores I
    Reprod Sci; 2015 Sep; 22(9):1134-42. PubMed ID: 25820690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins.
    Sewalt RG; Lachner M; Vargas M; Hamer KM; den Blaauwen JL; Hendrix T; Melcher M; Schweizer D; Jenuwein T; Otte AP
    Mol Cell Biol; 2002 Aug; 22(15):5539-53. PubMed ID: 12101246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers.
    Bae WK; Yoo KH; Lee JS; Kim Y; Chung IJ; Park MH; Yoon JH; Furth PA; Hennighausen L
    Mol Carcinog; 2015 Oct; 54(10):1172-80. PubMed ID: 25043748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pluripotency factors and Polycomb Group proteins repress aryl hydrocarbon receptor expression in murine embryonic stem cells.
    Ko CI; Wang Q; Fan Y; Xia Y; Puga A
    Stem Cell Res; 2014 Jan; 12(1):296-308. PubMed ID: 24316986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.